Next Phase Newsletter

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Digital Redefining Early Stage Investment (RESI) returns to JP Morgan in its successful virtual format January 11-13, 2022! JPM Week is the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.

Digital RESI levels the playing field by offering quality content and compelling programs, like the Innovator’s Pitch Challenge, and match-based partnering fraction of the cost of the other partnering conferences.

*Prices as of today

The team at Life Science Nation understands the financial, logistical, and other non-tangible barriers to entry when it comes to early-stage fundraising. This is why Digital RESI is affordable, accessible, and designed to connect partnerships that are based on product fit and stage of development. To ensure founders are set up for optimal success, we also feature several complimentary fundraising bootcamps available to the public to introduce founders to our system, as well as provide resources and proven strategies to help them get started on the right foot!

Get to know your business development representative to learn what Digital RESI has to offer you on your unique fundraising journey and sign up for Digital RESI JPM, January 11-13 by November 28 to save $300 on super early bird rates.

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast  (USA)
Greg Mannix Vice President International Business Development Book a Meeting	Candice He Vice President of Business Development, Global Investment Strategist Book a Meeting	Antoinette Lowre Manager of Business Development Book a Meeting	Alexander Vassallo Manager of Business Development Book a Meeting

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

It’s been a busy week at Life Science Nation! As the audience chatters and orchestra buzzes in the moments before curtain opens on a show, the week before Digital RESI November 16-18 has been filled with booking meetings, partnering tutorials, panel planning calls, and putting the finishing touches on pitch materials. The energy is in the air and there’s nothing like it!

Check out some of the content coming to you virtually through Digital RESI November next week. Each session has been carefully crafted to highlight the best in early-stage life science and healthcare, and every feature is designed to connect fundraising founders with investors and strategic partners who are a fit for their product and stage of development.

If you haven’t yet signed up for Digital RESI November, sign up now! There is still time, but meeting slots are booking up fast. If you’re already looking ahead to 2022, sign up for Digital RESI JPM early to save on super early bird rates!

By Caitlin Dolegowski, Marketing Specialist, LSN

Imagine learning critical components to successful fundraising from key experts and deal-makers in a virtual environment specific to early-stage life science and healthcare. It seems too good to be true until you check out the Digital RESI November lineup. Digital RESI November 16-18 offers attendees three days of panels, workshops and pitch sessions, each of which is designed to enrich the journey of early-stage, life science entrepreneurs with insight into what investors are looking for, how CEOs have found success and learning from other fundraising executives. Panel topics have been created to cover hot industry topics, with panelist recruitment focused on adding valuable content for fundraising attendees. Check out the panelists that will be presenting at this November’s conference below.

Partnering has begun for this conference and there is still time to register to attend!

Sangeeta Agarawal Co-Founder & CEO Helpsy Health	Cynthia Cai Venture Partner Viva BioInnovator	Mylea Charvat Principal & Partner LiquidSMARTS	Jonathan Cohen CEO 20/20 GeneSystems
Ruchi Dana Board Member Dana Group	Nissim Darvish Senior Managing Director (Israel) OrbiMed Advisors LLC	Dave Dlesk CEO Embrace Prevention Care	Keren Etkin Founder TheGerontechnologist
Lana Feng Co-Founder & CEO HumaAI Inc	Dave Fogel Member of Screening & Due Diligence Committees Mass Medical Angels	Michael Fossel President and Founder Telocyte	Les Funtleyder Chief Investment Officer TechNik
Shruti Gandhi Founder & Managing Partner Array Ventures	Ernst Geutjes Partner Aglaia Oncology Funds	Tom Gibbs Director Debiopharm Innovation Fund	Kimberly Ha Founder & CEO KKH Advisors
André Harrell Venture Partner Cancer Fund	Chihiro Hosoya BD/VC Head, Rx+ Business Accelerator Astellas Rx+ Business Accelerator	Baudouin Hue Partner Karista	Rachel Stillman, MBA Senior Associate 7wire Ventures
Taha Jangda Partner HealthX Ventures	Yury Kukushkin Investment Director JDRF T1D Fund	Pepper Landson CEO Praetego Inc	Taja Lester Managing Partner Health Equity Capital
Justin Leushner Partner Launchit Ventures	Richard Lipkin Co-Founder, Co-Chair The Catalytic Impact Foundation	Betsabeh Madani Hermann, MBA Life Science and Healthcare Investor and Advisor	Andrew Meadow General Partner Health Innovation Capital
Andy Merken Partner, Corporate and Securities Co-Chair, Life Sciences Burns & Levinson	Brian Meshkin Managing Partner Profound Ventures	Petra Meyer Managing Director – HealthCare Sector Group Lead Golden Seeds	Christos Monovoukas VP, Global M&A/Business Development Olympus Corporation
Alex Morgan Partner Khosla Ventures	Sasha Naydich Associate Myeloma Investment Fund	Rohit Pratap Singh Vice President, Investments Xeraya Capital	Rachel Rea Director of Business Development and Licensing Medtronic
Christina Salys Director of New Business Development Intuitive Surgical	Beth Sanders Founder & CEO LifeBio Inc	Diana Saraceni Founder, Managing Director Panakes Partners	Rachel Scherl CEO SPARK Solutions for Growth
DJ (Dennis) Schmitt Founder/CEO Neuro20 Technologies	Bryan Shao K4 Deal Screening Committee Keiretsu Forum	Xuhui Shao Managing Partner Foothill Ventures	Patrik Sobocki Investment Manager Life Science Industrifonden
Thomas Vogelsong Investor/Life Science Advisor/Director, Deal Flow KYTO Technology and Life Science	Richard Ward Director, Search and Evaluation, Oncology R&D BD AstraZeneca	Travis Whitfill Partner Bios Partners	Thierry Wurch Senior Director Ipsen S.A.
	Tiffany Yu Vice President Equality Asset Management LP	Lu Zhang Managing Partner Fusion Fund